Juri Bernardini

University of Pisa

Papers

1

Total Citations

52

H-Index

1

About

Dr. Juri Bernardini is a leading figure in the advancement of minimally invasive pancreatic surgery, with a primary research focus on optimizing oncologic outcomes for pancreatic cancer patients. His most impactful work centers on the comparative effectiveness of robotic versus open pancreatoduodenectomy, a technically demanding procedure. In his landmark 2018 study, which has garnered 52 citations, Dr. Bernardini employed rigorous propensity score matching to analyze margin status—a critical predictor of recurrence and survival. This research provided compelling evidence that robotic surgery can achieve comparable, if not superior, oncologic clearance to the traditional open approach, challenging long-held surgical dogmas. By demonstrating that minimally invasive techniques do not compromise radicality, his work has directly influenced clinical guidelines and expanded the adoption of robotic platforms in high-volume centers. Dr. Bernardini’s contributions are pivotal for surgeons seeking to reduce patient morbidity without sacrificing cancer control, establishing him as a key voice in the ongoing evolution of pancreatic cancer surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
52
Total Citations
52
Avg Citations/Paper
🏆 Most Cited Paper
A propensity score-matched analysis of robotic versus open pancreatoduodenectomy for pancreatic cancer based on margin status
52 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: University of Pisa

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago